17-beta-estradiol
Vulvodynia
Norwegian University of Science and TechnologyN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Vulvodynia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
LIDOCAINE Norwegian University of Science and Technology | Phase 3 | BB |
Pregabalin The Cleveland Clinic | Phase 2 | CCC |
Same molecule, other indications
17-beta-estradiol is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →